Ra Capital Management, L.P. Edgewise Therapeutics, Inc. Transaction History
Ra Capital Management, L.P.
- $6.64 Billion
- Q2 2024
A detailed history of Ra Capital Management, L.P. transactions in Edgewise Therapeutics, Inc. stock. As of the latest transaction made, Ra Capital Management, L.P. holds 8,909,091 shares of EWTX stock, worth $150 Million. This represents 2.42% of its overall portfolio holdings.
Number of Shares
8,909,091Holding current value
$150 Million% of portfolio
2.42%Shares
4 transactions
Others Institutions Holding EWTX
# of Institutions
144Shares Held
96.7MCall Options Held
45.7KPut Options Held
5.3K-
Orbimed Advisors LLC San Diego, CA15MShares$253 Million6.52% of portfolio
-
Novo Holdings Hellerup, G76.34MShares$107 Million8.16% of portfolio
-
Black Rock Inc. New York, NY6.02MShares$101 Million0.0% of portfolio
-
Baker Bros. Advisors LP New York, NY5.84MShares$98.4 Million1.4% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.51MShares$76 Million0.0% of portfolio
About Edgewise Therapeutics, Inc.
- Ticker EWTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 63,171,700
- Market Cap $1.06B
- Description
- Edgewise Therapeutics, Inc., a biopharmaceutical company, develops small molecule therapies for musculoskeletal diseases. The Company's lead product candidate, EDG-5506, is an orally administered small molecule designed to address the root cause of dystrophinopathies including Duchenne muscular dystrophy and Becker muscular dystrophy which has c...